Insider Transactions in Q1 2021 at Atreca, Inc. (BCEL)
Insider Transaction List (Q1 2021)
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Mar 17
2021
|
Norman Michael Greenberg Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
5,000
-100.0%
|
$80,000
$16.73 P/Share
|
Mar 17
2021
|
Norman Michael Greenberg Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+50.0%
|
$20,000
$4.86 P/Share
|
Mar 15
2021
|
William Hewitt Robinson Director |
SELL
Open market or private sale
|
Direct |
5,000
-1.34%
|
$80,000
$16.89 P/Share
|
Mar 11
2021
|
Tito Serafini |
SELL
Open market or private sale
|
Indirect |
10,000
-1.38%
|
$180,000
$18.53 P/Share
|
Feb 17
2021
|
Norman Michael Greenberg Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
5,000
-100.0%
|
$90,000
$18.95 P/Share
|
Feb 17
2021
|
Norman Michael Greenberg Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+50.0%
|
$25,000
$5.16 P/Share
|
Feb 16
2021
|
William Hewitt Robinson Director |
SELL
Open market or private sale
|
Direct |
5,000
-1.32%
|
$95,000
$19.07 P/Share
|
Feb 11
2021
|
Tito Serafini |
SELL
Open market or private sale
|
Indirect |
10,000
-2.67%
|
$180,000
$18.93 P/Share
|
Jan 19
2021
|
Norman Michael Greenberg Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
5,000
-100.0%
|
$75,000
$15.21 P/Share
|
Jan 19
2021
|
Norman Michael Greenberg Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+50.0%
|
$25,000
$5.16 P/Share
|
Jan 14
2021
|
William Hewitt Robinson Director |
SELL
Open market or private sale
|
Direct |
2,259
-0.59%
|
$33,885
$15.06 P/Share
|
Jan 13
2021
|
William Hewitt Robinson Director |
SELL
Open market or private sale
|
Direct |
2,741
-0.71%
|
$41,115
$15.05 P/Share
|
Jan 11
2021
|
Tito Serafini |
SELL
Open market or private sale
|
Indirect |
10,000
-2.61%
|
$150,000
$15.02 P/Share
|